Davidson T M, Jalowayski A, Murphy C, Jacobs R D
West J Med. 1987 Apr;146(4):434-8.
We gave 63 patients with symptoms of smell dysfunction a full evaluation by age-adjusted olfactory threshold and odor identification testing, rhinomanometry, nasal cytology, nasal endoscopy, computed tomographic (CT) scan and a trial of medical treatment. CT scans were valuable for identifying ethmoid sinus disease and nasal endoscopy for inspecting olfactory epithelium. A trial of prednisone served as a diagnostic modality to identify correctable causes of smell dysfunction. Given that there are 2 million people in the United States with a smell dysfunction, that the average physician knows little about its diagnosis and treatment and that the psychosocial impact to an afflicted person is great, we urge a greater awareness of smell dysfunction, its diagnosis and its treatment.
我们对63例有嗅觉功能障碍症状的患者进行了全面评估，包括年龄校正嗅觉阈值和气味识别测试、鼻阻力测量、鼻细胞学检查、鼻内镜检查、计算机断层扫描（CT）以及药物治疗试验。CT扫描对于识别筛窦疾病很有价值，鼻内镜检查则用于检查嗅觉上皮。泼尼松试验作为一种诊断方法，用于识别嗅觉功能障碍的可纠正病因。鉴于美国有200万人存在嗅觉功能障碍，普通医生对其诊断和治疗知之甚少，且嗅觉功能障碍对患者的心理社会影响很大，我们敦促提高对嗅觉功能障碍及其诊断和治疗的认识。
